Match investigations to the clinical question, and avoid treating uncertain results as definitive.
Persistent anginal symptoms should not be dismissed after non-obstructive coronary imaging; consider ischaemia with non-obstructive coronary arteries, vasospasm or microvascular dysfunction.
Match the test to the question
Define the clinical question before choosing the test. In chronic coronary disease, coronary CT angiography shows plaque, stenosis and anatomy. Stress echocardiography, single-photon emission computed tomography (SPECT), positron emission tomography (PET) and stress cardiac magnetic resonance address inducible ischaemia, perfusion and ventricular function. Pre-test likelihood, exercise capacity, baseline electrocardiogram, renal function, body habitus, rhythm, prior intervention and local expertise all influence which result will be useful.
An apparently reassuring anatomical study does not always resolve the problem. Persistent typical symptoms with non-obstructive coronaries may reflect ischaemia with non-obstructive coronary arteries, vasospasm or coronary microvascular dysfunction. The next assessment should remain mechanism-focused rather than simply repeating a test that has already failed to answer the clinical question.
Interpret uncertainty in context
Genetic testing creates a related but distinct interpretive problem. A negative test means that no causative variant has been identified with current knowledge and methods; it does not prove that a disorder is non-genetic. A variant of uncertain significance is not a confirmed diagnosis and should not drive irreversible management. Phenotype, family history, patient goals and the limits of the chosen test still matter. Panels, exome or genome sequencing, chromosomal arrays and karyotyping answer different questions.
At the bedside, peripheral neuropathy should first be described by symmetry, distribution and dominant deficit. A symmetrical, length-dependent, sensory-predominant pattern supports a clinical diagnosis, while rapid progression, asymmetry or prominent motor or autonomic features should prompt reconsideration and further testing. Adult attention problems also require a developmental timeline. Childhood examples, collateral history and key transition points matter because bipolar disorder, sleep problems, substance exposure, brain injury and cognition-impairing medicines can mimic or compound attention-deficit/hyperactivity disorder. Checklists and cognitive tests do not establish the diagnosis on their own.
Oral treatment requires selection
In carefully selected streptococcal, staphylococcal and enterococcal infective endocarditis, oral step-down therapy may replace prolonged intravenous treatment. Route alone does not determine efficacy, but safe switching depends on organism susceptibility, clinical stability, source control, oral absorption, regimen feasibility and multidisciplinary agreement. An undrained abscess or incomplete infection control is a reason not to switch. Avoiding long-term venous access may reduce thrombosis, line infection and treatment burden. Oral step-down should not be extrapolated automatically to other Gram-negative or fungal endocarditis.
Genetic results only become meaningful when interpreted alongside phenotype, family history and patient goals. Gene panels, exome and genome sequencing, chromosomal tests, pathogenic variants, negative findings and variants of uncertain significance answer different clinical and counselling questions.
Coronary CT angiography answers anatomical questions, while stress echocardiography, nuclear perfusion imaging, positron emission tomography and stress cardiac magnetic resonance assess ischaemia and function. Test selection depends on pre-test likelihood, symptoms, comorbidity, exercise capacity, ECG findings and local expertise.
Oral step-down therapy may replace prolonged intravenous treatment in carefully selected infective endocarditis when the organism, susceptibility, source control and regimen are suitable. Multidisciplinary review and highly bioavailable agents remain central to safe implementation.
Symmetry, distribution and the dominant neurological deficit should be described before assigning a cause. A typical distal sensory-predominant diabetic pattern directs foot assessment and focused investigation, while rapid progression, asymmetry or motor involvement warrants further testing.
Lifelong attention symptoms require a developmental timeline rather than a checklist alone. Bipolar disorder, sleep problems, substance exposure, brain injury, vascular or inflammatory disease and cognition-impairing medicines can mimic or compound adult attention-deficit/hyperactivity disorder.
Document the clinical pattern and the exact decision an investigation must inform before ordering it. Interpret negative or uncertain results against phenotype, family history and pre-test likelihood rather than treating them as definitive exclusions. Reassess persistent symptoms when coronary anatomy is non-obstructive, and continue phenotype-based care when genetic testing is inconclusive. Before oral step-down for infective endocarditis, confirm susceptibility, clinical stability, source control, oral absorption, regimen feasibility and multidisciplinary agreement.
An adult has persistent exertional central heaviness despite a near-normal coronary CT angiogram. What should further assessment consider?
Do not dismiss the symptoms solely because obstructive epicardial disease is absent. Consider functional or coronary function assessment for ischaemia with non-obstructive coronary arteries, vasospasm or coronary microvascular dysfunction.
Genetic testing identifies a variant of uncertain significance in a patient with suspected inherited disease. How should it influence management?
Do not treat it as a confirmed diagnosis or use it alone to drive irreversible management. Continue phenotype-based care and consider family segregation or later reinterpretation.
A clinically stable adult with susceptible streptococcal infective endocarditis is considered for oral step-down therapy, but an abscess remains undrained. What is the appropriate route decision?
Do not switch to oral therapy while source control remains incomplete. Address the undrained abscess before considering an oral regimen.
.svg)